These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26892341)

  • 1. RFT1-congenital disorder of glycosylation (CDG) syndrome: a cause of early-onset severe epilepsy.
    Aeby A; Prigogine C; Vilain C; Malfilatre G; Jaeken J; Lederer D; Van Bogaert P
    Epileptic Disord; 2016 Mar; 18(1):92-6. PubMed ID: 26892341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RFT1-CDG in adult siblings with novel mutations.
    Ondruskova N; Vesela K; Hansikova H; Magner M; Zeman J; Honzik T
    Mol Genet Metab; 2012 Dec; 107(4):760-2. PubMed ID: 23111317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RFT1-CDG: deafness as a novel feature of congenital disorders of glycosylation.
    Jaeken J; Vleugels W; Régal L; Corchia C; Goemans N; Haeuptle MA; Foulquier F; Hennet T; Matthijs G; Dionisi-Vici C
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S335-8. PubMed ID: 19856127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RFT1 deficiency in three novel CDG patients.
    Vleugels W; Haeuptle MA; Ng BG; Michalski JC; Battini R; Dionisi-Vici C; Ludman MD; Jaeken J; Foulquier F; Freeze HH; Matthijs G; Hennet T
    Hum Mutat; 2009 Oct; 30(10):1428-34. PubMed ID: 19701946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy.
    Barone R; Aiello C; Race V; Morava E; Foulquier F; Riemersma M; Passarelli C; Concolino D; Carella M; Santorelli F; Vleugels W; Mercuri E; Garozzo D; Sturiale L; Messina S; Jaeken J; Fiumara A; Wevers RA; Bertini E; Matthijs G; Lefeber DJ
    Ann Neurol; 2012 Oct; 72(4):550-8. PubMed ID: 23109149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital disorders of glycosylation.
    Jaeken J
    Handb Clin Neurol; 2013; 113():1737-43. PubMed ID: 23622397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive description of the phenotype of the first case of congenital disorder of glycosylation due to RFT1 deficiency (CDG In).
    Clayton PT; Grunewald S
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S137-9. PubMed ID: 19267216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epileptic spasms in congenital disorders of glycosylation.
    Pereira AG; Bahi-Buisson N; Barnerias C; Boddaert N; Nabbout R; de Lonlay P; Kaminska A; Eisermann M
    Epileptic Disord; 2017 Mar; 19(1):15-23. PubMed ID: 28300031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RFT1-CDG: Absence of Epilepsy and Deafness in Two Patients with Novel Pathogenic Variants.
    Quelhas D; Jaeken J; Fortuna A; Azevedo L; Bandeira A; Matthijs G; Martins E
    JIMD Rep; 2019; 43():111-116. PubMed ID: 29923091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroclinical Features of Early-Onset Epileptic Encephalopathies in Congenital Disorders of Glycosylation (CDGs).
    Fiumara A; Barone R; Del Campo G; Striano P; Jaeken J
    JIMD Rep; 2016; 27():93-9. PubMed ID: 26453362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A family with floppy neonates with severe respiratory insufficiency: A lethal phenotype of RFT1-CDG due to a novel mutation.
    Abiramalatha T; Arunachal G; Muthusamy K; Thomas N
    Eur J Med Genet; 2019 Apr; 62(4):248-253. PubMed ID: 30071302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of early onset epileptic encephalopathy with de novo mutation in SLC35A2: Clinical features and treatment for epilepsy.
    Kimizu T; Takahashi Y; Oboshi T; Horino A; Koike T; Yoshitomi S; Mori T; Yamaguchi T; Ikeda H; Okamoto N; Nakashima M; Saitsu H; Kato M; Matsumoto N; Imai K
    Brain Dev; 2017 Mar; 39(3):256-260. PubMed ID: 27743886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital disorders of glycosylation presenting as epileptic encephalopathy with migrating partial seizures in infancy.
    Barba C; Darra F; Cusmai R; Procopio E; Dionisi Vici C; Keldermans L; Vuillaumier-Barrot S; Lefeber DJ; Guerrini R;
    Dev Med Child Neurol; 2016 Oct; 58(10):1085-91. PubMed ID: 27172925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital disorder of glycosylation type Ij (CDG-Ij, DPAGT1-CDG): extending the clinical and molecular spectrum of a rare disease.
    Würde AE; Reunert J; Rust S; Hertzberg C; Haverkämper S; Nürnberg G; Nürnberg P; Lehle L; Rossi R; Marquardt T
    Mol Genet Metab; 2012 Apr; 105(4):634-41. PubMed ID: 22304930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case of ALG6-CDG with Explosive Onset of Intractable Epilepsy During Infancy.
    Clark DJ; Murray T; Drees M; Kulkarni N
    Child Neurol Open; 2023; 10():2329048X231153781. PubMed ID: 36756224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations.
    Milh M; Villeneuve N; Chouchane M; Kaminska A; Laroche C; Barthez MA; Gitiaux C; Bartoli C; Borges-Correia A; Cacciagli P; Mignon-Ravix C; Cuberos H; Chabrol B; Villard L
    Epilepsia; 2011 Oct; 52(10):1828-34. PubMed ID: 21770924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human RFT1 deficiency leads to a disorder of N-linked glycosylation.
    Haeuptle MA; Pujol FM; Neupert C; Winchester B; Kastaniotis AJ; Aebi M; Hennet T
    Am J Hum Genet; 2008 Mar; 82(3):600-6. PubMed ID: 18313027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation.
    Kato M; Yamagata T; Kubota M; Arai H; Yamashita S; Nakagawa T; Fujii T; Sugai K; Imai K; Uster T; Chitayat D; Weiss S; Kashii H; Kusano R; Matsumoto A; Nakamura K; Oyazato Y; Maeno M; Nishiyama K; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Saito K; Hayasaka K; Matsumoto N; Saitsu H
    Epilepsia; 2013 Jul; 54(7):1282-7. PubMed ID: 23621294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIGT-CDG, a disorder of the glycosylphosphatidylinositol anchor: description of 13 novel patients and expansion of the clinical characteristics.
    Bayat A; Knaus A; Juul AW; Dukic D; Gardella E; Charzewska A; Clement E; Hjalgrim H; Hoffman-Zacharska D; Horn D; Horton R; Hurst JA; Josifova D; Larsen LHG; Lascelles K; Obersztyn E; Pagnamenta A; Pal DK; Pendziwiat M; Ryten M; Taylor J; Vogt J; Weber Y; Krawitz PM; Helbig I; Kini U; Møller RS;
    Genet Med; 2019 Oct; 21(10):2216-2223. PubMed ID: 30976099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesis.
    Grünewald S; Imbach T; Huijben K; Rubio-Gozalbo ME; Verrips A; de Klerk JB; Stroink H; de Rijk-van Andel JF; Van Hove JL; Wendel U; Matthijs G; Hennet T; Jaeken J; Wevers RA
    Ann Neurol; 2000 Jun; 47(6):776-81. PubMed ID: 10852543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.